Publication Name	World Journal of Diabetes
Manuscript ID	29435
Country	Greece

Received	2016-08-14 11:41
Peer-Review Started	2016-08-16 11:42
To Make the First Decision	2016-09-02 14:20
Return for Revision	2016-09-05 11:47
Revised	2016-09-17 17:40
Second Decision	2016-10-31 17:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-11-17 15:12
Articles in Press	2016-11-17 15:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-28 14:03
Publish the Manuscript Online	2017-01-06 13:39

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Role of lipid-lowering agents in the management of diabetic retinopathy
Manuscript Source	Invited Manuscript
All Author List	Estelle Ioannidou, Vasilis-Spyridon Tseriotis and Konstantinos Tziomalos
Funding Agency and Grant Number
Corresponding Author	Konstantinos Tziomalos, MD, PhD, Assistant Professor of Internal Medicine, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi street, 54636 Thessaloniki, Greece. ktziomalos@yahoo.com
Key Words	Diabetes mellitus; Lipid-lowering agents; Statins; Fibrates; Ezetimibe; Colesevelam; Retinopathy
Core Tip	Even though it is unclear whether dyslipidemia is implicated in the pathogenesis of diabetic retinopathy, both preclinical data and two large randomized controlled studies showed that treatment with fenofibrate delays the progression of diabetic retinopathy. In contrast, statins do not appear to play a role in the management of this complication despite the promising findings of animal studies.
Publish Date	2017-01-06 13:39
Citation	Ioannidou E, Tseriotis VS, Tziomalos K. Role of lipid-lowering agents in the management of diabetic retinopathy. World J Diabetes 2017; 8(1): 1-6
URL	http://www.wjgnet.com/1948-9358/full/v8/i1/1.htm
DOI	http://dx.doi.org/10.4239/wjd.v8.i1.1

Full Article (PDF)	WJD-8-1.pdf
Full Article (Word)	WJD-8-1.doc
Manuscript File	29435-Review.docx
Answering Reviewers	29435-Answering reviewers.pdf
Audio Core Tip	29435-Audio core tip.wma
Conflict-of-Interest Disclosure Form	29435-Conflict-of-interest statement.pdf
Copyright License Agreement	29435-Copyright assignment.pdf
Peer-review Report	29435-Peer-review(s).pdf
Scientific Misconduct Check	29435-Scientific misconduct check.pdf
Scientific Editor Work List	29435-Scientific editor work list.pdf